Literature DB >> 24723003

The relationship between electrocardiographic changes and CMR features in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.

Xiuyu Chen1, Tao Zhao, Minjie Lu, Gang Yin, Wei Xiangli, Shiliang Jiang, Sanjay Prasad, Shihua Zhao.   

Abstract

To investigate the relationship between electrocardiographic (ECG) abnormalities and left ventricular (LV) segmental hypertrophy and myocardial fibrosis assessed by cardiovascular magnetic resonance (CMR) in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy (HCM). 118 asymptomatic or mildly symptomatic patients with HCM were examined with late gadolinium enhancement (LGE) CMR, 12-lead ECG, and echocardiography. The distribution and magnitude of LV segmental hypertrophy and LGE were assessed and analyzed in relation to ECG abnormalities. Abnormal electrocardiograms were found in 113 of 118 (95%) patients. Negative T waves were associated with greater apical septal thickness (P = 0.009) and an increased ratio of LV septum to free wall thickness (P = 0.01). Giant negative T waves (GNT) were found in 19 patients (16%), and were associated with apical HCM (P < 0.001), greater apical thickness (P = 0.004), and increased ratio of LV apical to basal wall thickness (P < 0.001). However, no significant association was demonstrated between GNT and apical LGE (P = 0.71). Abnormal Q waves were associated with greater basal anteroseptal thickness (P = 0.001), maximal basal thickness (P = 0.004), and more segments with extensive LGE (>75% wall thickness involved) (P = 0.001). LV hypertrophy was related to greater LV mass (P = 0.002) and LV end diastolic volume (P = 0.002). In addition, a modest but significant correlation was observed between maximum LV wall thickness and the Romhilt-Estes score (r = 0.41, P < 0.001). GNT were associated with apical HCM and an increased ratio of LV apical to basal wall thickness. Abnormal Q waves were related to basal anteroseptal hypertrophy and segmental extensive LGE.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24723003     DOI: 10.1007/s10554-014-0416-x

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  36 in total

1.  Mechanisms of abnormal Q waves in hypertrophic cardiomyopathy assessed by intracoronary electrocardiography.

Authors:  Yoshinori Koga; Akihiko Yamaga; Kohji Hiyamuta; Hisao Ikeda; Hironori Toshima
Journal:  J Cardiovasc Electrophysiol       Date:  2004-12

2.  Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging.

Authors:  Caitlin J Harrigan; Dana C Peters; C Michael Gibson; Barry J Maron; Warren J Manning; Martin S Maron; Evan Appelbaum
Journal:  Radiology       Date:  2010-11-02       Impact factor: 11.105

3.  Clinical significance of giant negative T waves in hypertrophic cardiomyopathy.

Authors:  F Alfonso; P Nihoyannopoulos; J Stewart; S Dickie; R Lemery; W J McKenna
Journal:  J Am Coll Cardiol       Date:  1990-04       Impact factor: 24.094

4.  Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy.

Authors:  Julia V Montgomery; Kevin M Harris; Susan A Casey; Andrey G Zenovich; Barry J Maron
Journal:  Am J Cardiol       Date:  2005-07-15       Impact factor: 2.778

5.  Hypertrophic cardiomyopathy: refining the lens of cardiac magnetic resonance to evaluate late gadolinium enhancement.

Authors:  David A Bluemke; Eunice Yang
Journal:  J Am Coll Cardiol       Date:  2012-09-04       Impact factor: 24.094

Review 6.  Cardiac magnetic resonance in hypertrophic cardiomyopathy.

Authors:  Andrew C Y To; Ashwat Dhillon; Milind Y Desai
Journal:  JACC Cardiovasc Imaging       Date:  2011-10

7.  Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy.

Authors:  Oliver Bruder; Anja Wagner; Christoph J Jensen; Steffen Schneider; Peter Ong; Eva-Maria Kispert; Kai Nassenstein; Thomas Schlosser; Georg V Sabin; Udo Sechtem; Heiko Mahrholdt
Journal:  J Am Coll Cardiol       Date:  2010-06-25       Impact factor: 24.094

8.  Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.

Authors:  Christian Prinz; Maria Schwarz; Ivan Ilic; Kai Thorsten Laser; Roman Lehmann; Eva-Maria Prinz; Thomas Bitter; Jürgen Vogt; Frank van Buuren; Nikola Bogunovic; Dieter Horstkotte; Lothar Faber
Journal:  Can J Cardiol       Date:  2012-06-30       Impact factor: 5.223

Review 9.  Hypertrophic cardiomyopathy.

Authors:  Perry Elliott; William J McKenna
Journal:  Lancet       Date:  2004-06-05       Impact factor: 79.321

10.  Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; J K Wolfson; E Ciró; P Spirito
Journal:  Am J Cardiol       Date:  1983-01-01       Impact factor: 2.778

View more
  10 in total

1.  Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.

Authors:  Gaetano Nucifora; Daniele Muser; Pasquale Gianfagna; Giorgio Morocutti; Alessandro Proclemer
Journal:  Int J Cardiovasc Imaging       Date:  2015-07-26       Impact factor: 2.357

Review 2.  Cardiovascular imaging 2014 in the International Journal of Cardiovascular Imaging.

Authors: 
Journal:  Int J Cardiovasc Imaging       Date:  2015-03       Impact factor: 2.357

3.  High ECG Risk-Scores Predict Late Gadolinium Enhancement on Magnetic Resonance Imaging in HCM in the Young.

Authors:  Anna Wålinder Österberg; Ingegerd Östman-Smith; Robert Jablonowski; Marcus Carlsson; Henrik Green; Cecilia Gunnarsson; Petru Liuba; Eva Fernlund
Journal:  Pediatr Cardiol       Date:  2021-01-30       Impact factor: 1.655

4.  Functional, morphological and electrocardiographical abnormalities in patients with apical hypertrophic cardiomyopathy and apical aneurysm: correlation with cardiac MR.

Authors:  Kenichiro Suwa; Hiroshi Satoh; Makoto Sano; Mamoru Nobuhara; Takeji Saitoh; Masao Saotome; Tsuyoshi Urushida; Hideki Katoh; Kei Tawarahara; Hayato Ohtani; Yasushi Wakabayashi; Hiroyuki Takase; Hajime Terada; Yasuo Takehara; Harumi Sakahara; Hideharu Hayashi
Journal:  Open Heart       Date:  2014-08-13

5.  Clinical Characteristics and Prognosis of End-stage Hypertrophic Cardiomyopathy.

Authors:  Yan Xiao; Kun-Qi Yang; Yan-Kun Yang; Ya-Xin Liu; Tao Tian; Lei Song; Xiong-Jing Jiang; Xian-Liang Zhou
Journal:  Chin Med J (Engl)       Date:  2015-06-05       Impact factor: 2.628

6.  Correlation of Electrocardiographic Changes with Cardiac Magnetic Resonance Findings in Patients with Hypertrophic Cardiomyopathy.

Authors:  Gabriela Miana de Mattos Paixão; Horácio Eduardo Veronesi; Halsted Alarcão Gomes Pereira da Silva; José Nunes de Alencar Neto; Carolina de Paulo Maldi; Luciano de Figueiredo Aguiar Filho; Ibrahim Masciarelli Francisco Pinto; Francisco Faustino de Albuquerque Carneiro de França; Edileide de Barros Correia
Journal:  Arq Bras Cardiol       Date:  2018-01       Impact factor: 2.000

7.  How are ECG parameters related to cardiac magnetic resonance images? Electrocardiographic predictors of left ventricular hypertrophy and myocardial fibrosis in hypertrophic cardiomyopathy.

Authors:  Zsofia Dohy; Andras Vereckei; Viktor Horvath; Csilla Czimbalmos; Liliana Szabo; Attila Toth; Ferenc I Suhai; Ibolya Csecs; David Becker; Bela Merkely; Hajnalka Vago
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-04-23       Impact factor: 1.468

8.  Preoperative myocardial fibrosis is associated with worse survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: A delayed enhanced cardiac magnetic resonance study.

Authors:  Youzhou Chen; Xingshan Zhao; Jiansong Yuan; Yan Zhang; Wei Liu; Shubin Qiao
Journal:  Front Cardiovasc Med       Date:  2022-08-11

9.  Association of electrocardiographic markers with myocardial fibrosis as assessed by cardiac magnetic resonance in different clinical settings.

Authors:  George Bazoukis; Sebastian Garcia-Zamora; Göksel Çinier; Sharen Lee; Enes Elvin Gul; Jesús Álvarez-García; Gabi Miana; Mert İlker Hayıroğlu; Gary Tse; Tong Liu; Adrian Baranchuk
Journal:  World J Cardiol       Date:  2022-09-26

10.  An Atypical Case of Apical Hypertrophic Cardiomyopathy: Absence of Giant T Waves in spite of Extreme Apical Wall Hypertrophy.

Authors:  Elias Sanidas; Maria Bonou; Georgios Anastasiadis; Georgios Tzanis; John Barbetseas
Journal:  Case Rep Cardiol       Date:  2015-12-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.